These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12814111)

  • 61. Adequate protection for the autonomous research subject? The disclosure of sources of funding and commercialisation in genetic research trials.
    Cote A
    Manit Law J; 2002; 28(3):347-58. PubMed ID: 15162817
    [No Abstract]   [Full Text] [Related]  

  • 62. Numerous violations of federal informed consent requirements.
    Maloney DM
    Hum Res Rep; 2004 Jan; 19(1):1-3. PubMed ID: 14997901
    [No Abstract]   [Full Text] [Related]  

  • 63. Failure to report and provide commentary on research ethics board approval and informed consent in medical journals.
    Finlay KA; Fernandez CV
    J Med Ethics; 2008 Oct; 34(10):761-4. PubMed ID: 18827111
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Financial conflicts of interest and protection of human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034
    [No Abstract]   [Full Text] [Related]  

  • 65. Federal case is settled over death of research subject.
    Maloney DM
    Hum Res Rep; 2005 Apr; 20(4):1-2. PubMed ID: 16018114
    [No Abstract]   [Full Text] [Related]  

  • 66. Protecting health information privacy in research: what's an ethics committee like yours doing in a job like this?
    Thomson C
    J Law Med; 2006 Feb; 13(3):304-10. PubMed ID: 16506724
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Informed consent: true information or institutional review board-approved disinformation?
    Rossel M; Burnier M; Stupp R
    J Clin Oncol; 2007 Dec; 25(36):5835-6. PubMed ID: 18089884
    [No Abstract]   [Full Text] [Related]  

  • 68. The use of placebos in clinical trials: responsible research or unethical practice?
    Hoffman S
    Conn Law Rev; 2001; 33(2):449-501. PubMed ID: 15732201
    [No Abstract]   [Full Text] [Related]  

  • 69. Johns Hopkins is investigating study in India by a professor.
    N Y Times Web; 2001 Jul; ():A15. PubMed ID: 12154825
    [No Abstract]   [Full Text] [Related]  

  • 70. Fast track to disaster? Considerations raised by the current recruitment techniques for clinical research subjects.
    Isidor JM; Kaltman SP
    J Biolaw Bus; 2002; 5(3):46-7. PubMed ID: 12816118
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Barriers to conducting clinical research in reproductive medicine: India.
    Pai H
    Fertil Steril; 2011 Oct; 96(4):809-10. PubMed ID: 21961915
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Institutional review board consideration of chart reviews, case reports, and observational studies.
    Neff MJ
    Respir Care; 2008 Oct; 53(10):1350-3. PubMed ID: 18811999
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current status of research on the federal guidelines for performing research using an exception from informed consent.
    Schmidt TA; Lewis RJ; Richardson LD
    Acad Emerg Med; 2005 Nov; 12(11):1022-6. PubMed ID: 16264068
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
    Puttagunta PS; Caulfield TA; Griener G
    Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
    [TBL] [Abstract][Full Text] [Related]  

  • 76. When informed consent is not required in studies.
    Maloney DM
    Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
    [No Abstract]   [Full Text] [Related]  

  • 77. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 78. Universities scramble to assess scope of falsified results.
    Dalton R
    Nature; 2005 Nov; 438(7064):7. PubMed ID: 16267515
    [No Abstract]   [Full Text] [Related]  

  • 79. [Therapeutic trial, clinical research and therapeutic freedom--legal boundaries].
    Deutsch E
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):698-700; discussion 701. PubMed ID: 9527472
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Going beyond parents and institutional review boards in protecting children involved in nontherapeutic research.
    Rubinstein E
    Gold Gate Univ Law Rev; 2003; 33(2):251-94. PubMed ID: 15164740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.